AST SpaceMobile, Rocket Lab and other space stocks face being dragged toward zero by SpaceX's stock drop. With SpaceX valued above $1 trillion, it can buy them out with all-equity offers, the mega-cap way, and that is already happening. x.comÂ
Roger
Business Owner, Former Assistant Research Professor
SpaceX's competitive threat makes AST SpaceMobile less attractive at these levels than SpaceX and Rocket Lab. AST SpaceMobile's weekly chart shows a downtrend and strong outflows, though the stock is near marked support. x.comÂ
AST SpaceMobile is likely to suffer more, and for longer, from the SpaceX IPO's drawdown because it is a smaller stock. Weeks after listing, everyone who bought SpaceX is underwater, and the whole space sector has fallen alongside it. x.comÂ
Investors rotating into cheaper stocks with more upside should ultimately benefit Rocket Lab and AST SpaceMobile. Both have already suffered major drawdowns. x.comÂ
Space stocks have lost their catalyst now that SpaceX is public. For a year the basket was a bet on when the SpaceX IPO would happen; it listed Friday, up 19% at $2.1 trillion, the biggest IPO in history, and the air came out. Rocket Lab, AST SpaceMobile, Satellogic and BlackSky, green for months, have all flipped to SuperTrend downtrends. That is not the sector breaking but buy-the-rumor, sell-the-news. x.comÂ
Rocket Lab and SpaceX are the preferred space names as SpaceX is killing it right now, while AST SpaceMobile has only a very small chance of returning to its highs. x.comÂ
A stronger SpaceX could lift the wider space-stock basket, including AST SpaceMobile, Rocket Lab, Redwire, Planet Labs, Intuitive Machines, Firefly Aerospace and Voyager Technologies. Per DeItaone, JPMorgan raised its SpaceX price target from $240 to $500 while maintaining Overweight. The seven space stocks rose alongside SpaceX after hours. Their initial post-IPO selloff was followed by macro-driven weakness, not further weakness caused by SpaceX. x.com x.com x.comÂ
Rocket Lab and AST SpaceMobile are not buys because their sales multiples are too high, even after the selloff. Rocket Lab trades at 30x sales after a 14% drawdown, while AST SpaceMobile trades at 138x sales. x.comÂ
AST SpaceMobile's reliance on competitor SpaceX for satellite launches weakens its moat further. SpaceX has bought its own spectrum, raising competitive risk. Piper Sandler downgraded ASTS over the pace of 2026-27 launches and SpaceX's potential to limit launch availability or undercut service pricing, though the bank remains constructive beyond 2027. x.comÂ
Space stocks could regain high-beta flows as SpaceX lockups end and a probable late-November Anthropic IPO threatens AI stocks, much as SpaceX's IPO hurt space names. Hedge funds are overexposed to the Magnificent Seven and underexposed or max short low-quality high beta; falling rates and toppy oil could make the rotation painful for them through 2027. AST SpaceMobile could benefit as intermittent service triggers agreements and Blue Origin possibly returns to the pad in six weeks. x.com x.comÂ
Rocket Lab's Neutron delay could drag public space stocks down because the space basket usually trades together. Rocket Lab is likely to pull AST SpaceMobile down with it, especially in a bad market. The delay also pushes back a possible AST launch on Neutron, though that launch was not expected and the news is not necessarily bad for AST directly. x.com x.com x.comÂ